Anticoagulants

Department of Health written question – answered on 8th December 2014.

Alert me about debates like this

Photo of Andrew Gwynne Andrew Gwynne Shadow Minister (Health)

To ask the Secretary of State for Health, if he will make an assessment of the findings of AntiCoagulation Europe's report, Ready for change? Understanding and improving anticoagulation services, published in October 2014 on the readiness of clinical commissioning groups to plan and assess the effectiveness of anticoagulation services; and if he will make a statement.

Photo of Andrew Gwynne Andrew Gwynne Shadow Minister (Health)

To ask the Secretary of State for Health, what guidance he has issued to help clinical commissioning groups redesign services to take into account the views of patients and the latest innovations in testing, self-management and anticoagulation therapy.

Photo of Andrew Gwynne Andrew Gwynne Shadow Minister (Health)

To ask the Secretary of State for Health, what guidance he has issued to help clinical commissioning groups ensure that patients who need anticoagulant treatment are given access to the full range of NICE-approved treatments and informed about the range of treatments available to them.

Photo of Andrew Gwynne Andrew Gwynne Shadow Minister (Health)

To ask the Secretary of State for Health, what guidance he has issued to help clinical commissioning groups work with providers to collect information on the (a) patient experience of people who use anticoagulation services, (b) quality of local anticoagulation services and (c) clinical outcomes for people who use those services.

Photo of Jane Ellison Jane Ellison The Parliamentary Under-Secretary of State for Health

NHS England and clinical commissioning groups (CCGs) have responsibility for services for patients who receive anticoagulation treatments.

It is for individual CCGs to commission treatment and services for patients on anticoagulation treatment or other medications which require monitoring, as they are best placed to identify what is needed in their local areas.

There is guidance in place to support CCGs in planning services for patients who receive anticoagulation treatments. Under its Diagnostics Assessment Programme, the National Institute for Health and Care Excellence (NICE) has published guidance on self-monitoring of anticoagulation treatments. It has also published updated guidance on the management and treatment of atrial fibrillation (AF) which makes recommendations on the use of newer anticoagulants. NHS England expects CCGs to take account of NICE guidance when commissioning services for patients on anticoagulation treatments. Many Strategic Clinical Networks also have programmes in place to support CCGs to develop these services, including the GRASP AF tool and the Anticoagulation Europe’s report will help drive forward improvements in this area.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.